Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Osteocalcin -

Osteocalcin

Production, Regulation & Disease

Masayoshi Yamaguchi (Herausgeber)

Buch | Hardcover
173 Seiten
2012
Nova Science Publishers Inc (Verlag)
978-1-61942-047-2 (ISBN)
CHF 195,80 inkl. MwSt
  • Versand in 10-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Osteocalcin is a hydroxyapatite-binding protein, which is present in bone as the most abundant non-collagenous protein. Osteocalcin is exclusively synthesised by osteoblasts. In recent years, osteocalcin, which is secreted in the general circulation from osteoblastic cells, has been shown to have several hormonal features, and it has been shown to act either as a cytokine or as a chemoattractant for osteoblasts, osteoclasts and blood monocytes and to involve in endocrine regulation of glucose homeostasis. Thus, the novel role of osteocalcin in the regulation of many functions in the living body was found in recent studies. This book will be of help in the understanding of the wide aspects of the functional role of osteocalcin and its significance in disease.

Masayoshi Yamaguchi, Ph.D., IOM, FAOE, DDG, DG, is Adjunct Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA (2013 - ). Dr. Yamaguchi is engaged in the fields of endocrinology and cell signaling since 1971, and these researches are developed in the aspect of biochemistry, molecular biology, endocrinology, metabolism, nutrition, pharmacology, and toxicology. Dr Yamaguchi has an interesting for cell signaling mechanism, bone biology, nutritional factor and osteoporosis prevention, diabetes and diabetic osteoporosis, cancer biology, and cancer cell bone metastasis. Dr. Yamaguchi discovered two novel proteins and genes; cell signaling suppressor protein (named regucalcin; 1978) and transcriptional factor RGPR-p117 (regucalcin gene promoter region-related protein; 2001). Dr Yamaguchi generated regucalcin transgenic rats, which were registered as international patents including USA, EU and Japan, and this animal was found to induce osteoporosis and hyperlipidemia. Moreover, Dr. Yamaguchi proposed the potential role of regucalcin as a key suppressor protein in carcinogenesis. Thus far, Dr Yamaguchi published over 550 English articles to professional journals with peer-review, and registered over 20 national and international patents.

Osteocalcin: from bone to vessel; Osteogenic effects of an electromagnetic stimulation on human Mesenchymal stromal cells seeded onto gelatin cryogel; Osteocalcin expression in cells: recent research in dentistry; The roles of osteocalcin in bone-related disorders; Vitamin K & osteocalcin: Role in osteoporosis prevention; Is the Use of bone biomarkers, imaging & histomorphometry in safety pharmacology studies a necessity or a luxury?; Osteocalcin as an endocrine factor; Osteocalcin & glucose metabolism; Osteocalcin: a link between bone, energy metabolism & disease.

Verlagsort New York
Sprache englisch
Maße 155 x 230 mm
Gewicht 288 g
Themenwelt Medizinische Fachgebiete Innere Medizin Rheumatologie
ISBN-10 1-61942-047-3 / 1619420473
ISBN-13 978-1-61942-047-2 / 9781619420472
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Alexander Pfeil; Peter Oelzner; Joachim Böttcher

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 61,60
Information für Erkrankte, Angehörige und Betreuende

von Matthias Schneider

Buch | Softcover (2023)
Springer (Verlag)
CHF 32,15